Cargando…
Tocilizumab: Viral myocarditis, increased viral replication and worsening of COVID-19 following off-label use: 2 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366435/ http://dx.doi.org/10.1007/s40278-020-80977-9 |
Ejemplares similares
-
Tocilizumab: Infection and worsening of pre-existing COVID-19 symptoms following off-label treatment: case report
Publicado: (2021) -
Dexamethasone/tocilizumab: Worsening of hepatitis E virus infection following off label use: case report
Publicado: (2022) -
Tocilizumab: Hepatitis-B viral reactivation with acute hepatitis following an off-label treatment: case report
Publicado: (2021) -
Methylprednisolone/prednisone: Accelerated viral replication following an off-label treatment: case report
Publicado: (2020) -
Tocilizumab: Anaphylaxis following off-label use: case report
Publicado: (2021)